by Eric Christianson | Dec 8, 2024 | Infectious Disease and Oncology Medication and Disease State Clinical Pearls
Fosfomycin is an antibiotic (discovered in 1969) that has been making a resurgence in popularity in the last few years due to its activity against both gram-positive and gram-negative bacteria. Currently, it is a treatment option for women with uncomplicated urinary...
by Eric Christianson | Dec 4, 2024 | Clinical Pharmacy News and New Drug Updates
For decades, the clozapine REMS program was one of the most well-known safety initiatives done by the FDA. The program was designed to reduce the risk of severe neutropenia. This REMS program has also been a popular target for board exam questions. But is the...
by Eric Christianson | Nov 27, 2024 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Methenamine is a medication used for urinary tract infection (UTI) prophylaxis, however, it is not considered a traditional antibiotic. It works by acidifying the urine and essentially making it sterile by killing off existing bacteria in the urinary tract and...
by Eric Christianson | Nov 24, 2024 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls
Insulin icodec may have a new competitor in the near future. Insulin efsitora is another once-weekly insulin currently undergoing phase 3 clinical trials, with Lilly’s 3rd phase being termed the QWINT trials (Once Weekly (QW) Insulin Therapy (INT)). These trials are...
by Eric Christianson | Nov 20, 2024 | Renal, Urology, and Electrolytes Case Studies
A 75-year-old female has a history of mild cognitive impairment, GERD, hypertension, osteoarthritis, and overactive bladder. Recognizing the relationship of oxybutynin and cognitive impairment is incredibly important in geriatrics and in the case scenario, we outline...
